TCGX Acquisition Corp. II (TCXB)
TCGX Acquisition Corp. II will go public soon, but the exact IPO date is still unknown.
IPO Price
$10.00
Shares Offered
10,000,000
Deal Size
$100.00M
Company Description
TCGX Acquisition II is a blank check company incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
We intend to target companies in the life sciences and medical technology sectors, where our management and TCGX (as defined below) have extensive investment experience.
TCGX Acquisition Corp. II
| Country | United States |
| Founded | 2026 |
| Industry | Shell Companies |
| Sector | Financials |
| CEO | Dr. Chen Yu |
Contact Details
Address: 245 Lytton Ave., Suite 350 Palo Alto, CA 94301 United States | |
| Phone | 650-924-9424 |
Stock Details
| Ticker Symbol | TCXB |
| Exchange | NASDAQ |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 2149916 |
| Employer ID | 98-1949103 |
Key Executives
| Name | Position |
|---|---|
| Chen Yu, M.D., M.B.A. | Chief Executive Officer and Director |
| Craig Skaling | Chief Financial Officer and Director |
| Joshua Cohen | Director Nominee |
| Mark McKenna | Director Nominee |
| Michael Henderson | Director Nominee |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 25, 2026 | S-1 | General form for registration of securities under the Securities Act of 1933 |